Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280904 · ClinicalTrials.gov registry record
A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus
A clinical trial, sponsored by Codman & Shurtleff.
- Completed
- Registry status
- 433
- Enrollment target
NCT00280904: Completed study, sponsored by Codman & Shurtleff.
NCT00280904 is a clinical trial that has completed, run by Codman & Shurtleff. The registered enrollment target is 433 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00280904 has completed, sponsored by Codman & Shurtleff.
- COMPLETED
- Registry status
- 433 participants
- Enrollment target
Study Summary
The purpose of this Registry is to compare shunt/catheter-related infection rates among various shunt systems when used according to hospital standard of care to treat hydrocephalus.
Primary Outcome
Number of shunt infections occurring in subjects implanted with antibiotic impregnated catheters and standard catheters.
Interventions
- DEVICE Shunt catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 433 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-04 |
What the finished NCT00280904 record still lists
NCT00280904 is an observational study that tracks outcomes without assigning an intervention. The registered 433 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Shunt catheter is the first listed.
NCT00280904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00280904 about?
NCT00280904 is a clinical study titled "A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus". The purpose of this Registry is to compare shunt/catheter-related infection rates among various shunt systems when used according to hospital standard of care to treat hydrocephalus.
What is the current status of trial NCT00280904?
This trial is currently completed. The enrollment target is 433 participants. The study started on 2006-01. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00280904?
The interventions under investigation include: Shunt catheter (DEVICE).
Who is sponsoring clinical trial NCT00280904?
This trial is sponsored by Codman & Shurtleff, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia